Medical device and MedTech insights, news, tips and more

Lydus Medical Announces FDA Clearance of Vesseal™, The Microvascular Anastomosis Aid Device for Small Arteries

January 9, 2023


Lydus Medical is pleased to announce that the Vesseal™ has received FDA clearance 510(k). The Vesseal™ is a microvascular anastomosis suture deployment system, for standardized omni-vessel anastomoses, enabling simple, fast, safe, and effective procedures.

An anastomosis is one of the most complicated steps of microvascular surgery and fundamental to the success of these demanding surgical interventions. Varied clinical fields require micro-vascular anastomosis. These include breast reconstruction; head and neck reconstruction; surgical lymphedema treatment LVA; and vascular access for hemodialysis. Until now, microvascular anastomoses have been performed manually. Manual micro-anastomoses are time and labor intensive, require a long learning curve, a unique skill set and great surgical dexterity. The Vesseal™ is designed to mimic the skill set and dexterity needed to deliver quality patient care in microsurgical anastomoses. It provides, simple, accurate, dependable and consistent results through symmetrical placement of eight micro-sutures at the anastomosis site.

“FDA clearance of the Vesseal™ is a significant milestone both for innovation in microvascular anastomoses, and for Lydus Medical. It is common knowledge that there are large clinical unmet needs around microvascular anastomosis,” said Jessica Weiss, CEO Lydus Medical. “Clinicians who used the Vesseal™ stated that it shows a significant advantage over the manual anastomosis and provides more consistency in the procedure. We believe that the Vesseal™ will support enhanced outcomes in microsurgical procedures, as well as improved patient care.”

Simplifying microvascular anastomoses, the Vesseal™ will be available for purchase in the USA from January 2023 via select distributing partners, to support surgeons and patients alike.

Lydus Medical

A portfolio company of Sanara Ventures, a joint venture of Teva and Philips, Lydus was founded in 2017. Located in Israel, within the thriving biotech environment, Lydus is focused upon developing novel medical device products for small blood vessel anastomoses, to enable safe, simple, fast and effective procedures. Lydus Medical’s pipeline includes a diverse product portfolio, all based on patented inventions.

See Full Press Release at the Source: Lydus Medical Announces FDA Clearance of Vesseal™, The Microvascular Anastomosis Aid Device for Small Arteries

Press Release by: Lydus Medical

Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 17 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?
Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.